Table 2.
Exposure | Outcome | No. of SNPs | MR‐Egger regression | MR PRESSO | Heterogeneity analyses | ||||
---|---|---|---|---|---|---|---|---|---|
Intercept | p_intercept | Global test p | Correct p * | Method | Q | Q_pval | |||
Critically ill COVID‐19 | LTL | 6 | 0.001 | 0.885 | 0.004 | 0.174 | IVW | 29.853 | <0.001 |
MR‐Egger | 29.677 | <0.001 | |||||||
The reverse MR analyses | |||||||||
LTL | Critically ill COVID‐19 | 97 | −0.006 | 0.352 | 0.485 | NA | IVW | 90.434 | 0.497 |
MR‐Egger | 89.465 | 0.496 |
Abbreviations: IVW, inverse variance weighted; LTL, leukocyte telomere length; MR PRESSO, Mendelian randomization pleiotropy residual sum and outlier; SNPs, single‐nucleotide polymorphisms.
If MR PRESSO global test detects the horizontal pleiotropy and there is a significant difference before and after removing the outlier, correct p is calculated by removing instruments variants that have horizontal pleiotropy.